Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0100
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density ; day:1 ; month:12 ; year:2018 ; pages:1-8
Endocrine ; (1.12.2018), 1-8
- Creator
-
Rymuza, Joanna
Popow, Michał
Żurecka, Zuzanna
Przedlacki, Jerzy
Bednarczuk, Tomasz
Miśkiewicz, Piotr
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12020-018-1823-x
- URN
-
urn:nbn:de:101:1-2019011823560500974830
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rymuza, Joanna
- Popow, Michał
- Żurecka, Zuzanna
- Przedlacki, Jerzy
- Bednarczuk, Tomasz
- Miśkiewicz, Piotr
- SpringerLink (Online service)
Other Objects (12)
Recurrence of optic nerve neuropathy - a possible side effect of intravenous methylprednisolone pulses treatment
The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study
Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders
Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study
Recurrence of optic nerve neuropathy - a possible side effect of intravenous methylprednisolone pulses treatment
The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study
Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders
Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study
Recurrence of optic nerve neuropathy - a possible side effect of intravenous methylprednisolone pulses treatment
The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study
Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders
Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy